TBK1 and prostate cancer: For instance, the knockdown of TBK1 (TANK binding kinase 1), a negative regulator of mTORC1, decreases prostate cancer stem-like cell number and drug resistance, while rapamycin induces cell cycle arrest and enhances chemoresistance [242].